Therefore, although sorafenib could inhibit cell proliferation in HCC, it affected the level of PFKFB3 through time-specific mediation of IL-6/HIF-1α at different times, thereby affecting the cell invasion in HCC. The gene discussed is PFKFB3; the disease is hepatocellular carcinoma.